Dolutegravir intermediate-1 是 Dolutegravir 的一种新合成中间体，来自专利 WO 2016125192 A2。 它是一种整合酶抑制剂，有潜力研究人类免疫缺陷病毒 (HIV)-1 感染。

Dolutegravir intermediate-1 is a new synthetic Dolutegravir intermediate extracted from patent WO 2016125192 A2. Dolutegravir is an integrase inhibitor developed for the treatment of human immunodeficiency virus (HIV)-1 infection.

1335210-23-5

C13H17NO8

315.28

1-(2,2-dimethoxyethyl)-5-methoxy-6-methoxycarbonyl-4-oxopyridine-3-carboxylic acid;1-(2,2-dimethoxyethyl)-5-methoxy-6-(methoxycarbonyl)-4-oxo-1,4-dihydropyridine-3-carboxylic acid

DMSO:100 mg/mL (285.46 mM),Need ultrasonic
Powder: -20°C for 3 years
In solvent: -80°C for 2 years